FluidAI Medical is a medical platform company focused on enhancing global patient care through the innovative application of artificial intelligence in post-operative recovery. The company has developed a smart catheter system that fosters a proactive approach to post-operative care delivery. By utilizing data generated within the body, FluidAI's platform aids in the early detection of postoperative complications, allowing healthcare providers to access critical health information promptly. This technology aims to improve patient outcomes and streamline the management of post-operative recovery processes.
Eli is a company focused on empowering women to manage their health by providing insights into their hormone profiles. It has developed an at-home device that monitors hormones using saliva samples, allowing for daily tracking of hormonal changes. Alongside the device, Eli offers an app that delivers personalized insights based on the collected data. The primary aim of Eli is to offer women a reliable and effective means to take charge of their fertility and contraception choices, thereby enhancing their overall health and well-being.
LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. The company is creating experiences to assist consumers and employers all over the world in better managing anxiety and stress. They have created wellness-focused experiences that deliver benefits in as little as 5 minutes using innovative human-centered design at the intersection of art, science, and technology.
FluidAI
Seed Round in 2022
FluidAI Medical is a medical platform company focused on enhancing global patient care through the innovative application of artificial intelligence in post-operative recovery. The company has developed a smart catheter system that fosters a proactive approach to post-operative care delivery. By utilizing data generated within the body, FluidAI's platform aids in the early detection of postoperative complications, allowing healthcare providers to access critical health information promptly. This technology aims to improve patient outcomes and streamline the management of post-operative recovery processes.
iApotheca
Angel Round in 2021
iApotheca is a pharmacy software company focused on developing and implementing custom business applications that enhance pharmacy operations. The company specializes in prescription delivery software aimed at increasing the revenue of pharmacies. Its solutions facilitate the management of delivery services, allowing pharmacies to efficiently create delivery runs, add orders, and track patients. By streamlining these processes, iApotheca enables pharmacies to improve their operational efficiency and remain competitive in the market.
Qualisure Diagnostics
Pre Seed Round in 2020
Qualisure Diagnostics is a biotechnology company focused on making precision oncology the standard of care through the development of innovative diagnostic tools. The company harnesses big data and machine learning, utilizing proprietary algorithms to analyze extensive genomic databases and identify key biomarkers linked to patient survival outcomes. This capability allows for the creation of diagnostic tests that provide oncologists with vital biological information to tailor cancer treatment plans effectively. By minimizing unnecessary surgeries and treatments, Qualisure Diagnostics aims to enhance patient outcomes while also reducing healthcare costs. Their cloud-based platform enables global deployment of these diagnostic tests, supported by a central marketplace that simplifies test selection, ordering, and data exchange among healthcare stakeholders. Ultimately, Qualisure Diagnostics empowers physicians, patients, and other test developers with actionable insights, contributing to a more effective and efficient cancer care approach.
ManagingLife
Convertible Note in 2017
ManagingLife is a company dedicated to enhancing the quality of life for individuals living with chronic pain through its innovative digital solution, Manage My Pain. This clinically-validated platform enables users to track and analyze their pain, facilitating communication with healthcare providers and insurance companies. By leveraging a proprietary data asset, ManagingLife empowers both patients and clinicians to better manage pain, ultimately leading to improved patient outcomes and reduced healthcare costs. The solution is recognized as the most downloaded and top-ranked pain management app, with over 80,000 users worldwide and licensing agreements with hospitals, health systems, and insurers across North America. Through its SaaS-based offering, ManagingLife aims to transform pain management practices and reduce the financial burden associated with chronic pain for insurers and health systems.